This 21-marker panel checks liver, kidney, lipid and blood sugar markers alongside lipase, designed for people taking Ozempic (semaglutide) who want to monitor how their body is responding to treatment.
21 biomarkers as listed by Blue Horizon Medicals.
This panel is built for people taking semaglutide, the active ingredient in Ozempic, whether prescribed for type 2 diabetes or used off-label for weight management. It covers kidney markers (sodium, urea, chloride, eGFR, creatinine), liver markers (total protein, albumin, globulin, ALP, ALT, AST, GGT, bilirubin), a lipid profile, HbA1c for blood sugar, and lipase, an enzyme produced by the pancreas. These are the kinds of markers clinicians commonly use to keep track of how the body is adjusting during treatment.
With 21 biomarkers it scores strongly for clinical depth, in the upper quarter of the metabolism tests we track. Its price sits close to the median for panels of this size. The main limitation is collection: it requires a venous blood draw at a clinic, with a nurse home visit as the only alternative, and turnaround is around five days rather than a same-day or next-day result.
The listing explains each group of markers and why they matter in some detail, which supports a strong clarity score, though it does not describe the report format. A doctor reviews your results, and trust signals draw on Blue Horizon Medicals' 4.2 Trustpilot rating from 395 reviews, UKAS-accredited partner labs, and more than 17 years trading. Blue Horizon offers a near-identical panel for Mounjaro (tirzepatide) users at the same price, so the choice between the two mainly comes down to which medication you are actually taking.
This is aimed at people currently taking semaglutide, whether as Ozempic for diabetes or for weight management, who want to track liver, kidney, lipid and blood sugar markers through treatment. The provider suggests a baseline test before starting and a re-check every three months or after a dose increase. If you are taking tirzepatide instead (Mounjaro or Zepbound), Blue Horizon's separate Mounjaro Monitoring Blood Test covers the same 21 markers and is the more relevant choice.
A sample is taken by venous blood draw, either at a clinic or during a nurse home visit; there is no at-home finger-prick option for this test. Once the sample reaches the lab it is processed and a doctor reviews the results before your report is issued, typically within around five days of collection.
Aimed at people taking Ozempic (semaglutide), this panel checks 21 liver, kidney, lipid, protein and pancreas markers alongside HbA1c for £129.75. It is priced close to the median for similarly sized metabolism panels we track. As with Blue Horizon's equivalent Mounjaro test, it needs a venous blood draw at a clinic or nurse visit rather than an at-home kit, and results take around five days.
The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
21 biomarkers, placing it in the 78th percentile of metabolism tests we track.
A blood sample taken at home by a visiting nurse or phlebotomist; with a venous or clinic option as well; a home nurse visit is offered; results in around 5 days, in line with or faster than similar tests.
Results are reviewed by a doctor; the provider does not describe the report format.
Trustpilot 4.2 from 395 reviews; accredited lab (UKAS ISO 15189 partner labs); trading 17+ years.
£129.75 against a median of £124.38 for the 14 similarly sized metabolism tests we track (+4%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Mid-depth metabolic panel priced well below peers
Measures 19 markers of blood sugar, cholesterol, liver, kidney and inflammation to give a broad view of metabolic health.
Below-median price for a single-marker uric acid test
A single-marker blood test measuring uric acid, used to help monitor gout risk and related joint, kidney and metabolic health.
Broad 21-marker panel for people on oral semaglutide
A 21-marker blood panel covering kidney, liver, lipid and blood sugar markers plus lipase, aimed at people taking oral semaglutide (Rybelsus) who want to monitor how their body is responding over time.
21-marker organ and metabolic check for Tirzepatide users
This 21-marker panel checks liver, kidney, lipid and blood sugar markers alongside lipase, aimed at people taking Tirzepatide (sold as Mounjaro or Zepbound) who want to monitor how their body is responding to the medication.
